Avita Medical | 1811094D - Interest Expense On Debt

Stock Price
1.22
Daily Change
-0.01 -0.41%
Monthly
9.46%
Yearly
-58.81%
Q1 Forecast
1.19

Avita Medical reported AUD1.25M in Interest Expense on Debt for its fiscal semester ending in June of 2025.





Interest Expense On Debt Change Date
Celltrion KRW 19B 1.96B Jun/2025
Clinuvel Pharmaceuticals AUD 2.43M 414.48K Jun/2024
Cochlear AUD 2.65M 3.05M Jun/2025
CSL USD 104M 136M Jun/2025
Cspc Pharmaceutical CNY 10.19M 4.73M Sep/2025
Dianthus Therapeutics USD 4.44M 263K Sep/2024
Divis Laboratories Ltd INR 30M 20M Jun/2025
Kangmei Pharma CNY 1.82M 150K Sep/2025
Knight Therapeutics CAD 2.37M 6K Sep/2025
Laboratorios Farma EUR 699K 666.2K Jun/2025
Mayne Pharma AUD 1.2M 50K Jun/2024
Medical Developments International AUD 18K 3K Jun/2025
Nanosonics AUD 779K 94K Jun/2025
Neuren Pharmaceuticals AUD 0 0 Jun/2024
Paradigm Biopharmaceuticals AUD 1000 3K Jun/2025
Pharma Mar EUR 117K 1.24M Sep/2025
Polynovo AUD 506K 130K Jun/2025
PYC Therapeutics AUD 17K 11K Jun/2025
Qiagen NV USD 8.22M 615K Sep/2025
Ramsay Health Care AUD 316.1M 10.4M Jun/2025
ResMed USD 775K 886K Dec/2024
Sartorius EUR 49.5M 8.1M Sep/2025
Sino Biopharmaceutical CNY 76.87M 114.23M Jun/2024
Telix Pharmaceuticals AUD 18.84M 15.45M Jun/2025
Tilray USD 6.7M 2.73M Jun/2025
Zz Pientze Pharmaceu CNY 46.05M 36.5M Jun/2025